MedTrace Logo

CrossFit Exercise to Improve Glucose Control for Overweight and Obese Adults

NCT02185872 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 23

Last updated 2015-03-31

No results posted yet for this study

Summary

The purpose of this study was to examine the differences in glucose control, fitness, and body composition between a standard aerobic and resistance exercise training program and a shorter-duration, high-intensity CrossFit training program in overweight and obese physically inactive adults.

Hypotheses:

1. Both groups would improve glucose control, with the CrossFit group improving significantly more than the aerobic and resistance training group.
2. Both groups would improve fitness, with the CrossFit group improving significantly more than the aerobic and resistance training group.
3. Both groups would demonstrate decreases in body fat percentage and fat mass and increases in lean body mass, with the CrossFit group improving significantly more than the aerobic and resistance training group.

Conditions

Interventions

OTHER

High-Intensity Functional Training

Participants were instructed to work as hard as they could while maintaining safe technique and proper form to achieve as many reps or rounds as possible in the prescribed time frame. As HIFT participants became accustomed to specific movements, less time was dedicated to practicing movements and technique.

OTHER

Aerobic and Resistance Training

The protocol was based upon current guidelines of 150 minutes moderate-intensity aerobic activity and 2 days of muscle strengthening per week.

Sponsors & Collaborators

  • Kansas State University

    lead OTHER

Principal Investigators

  • Katie M Heinrich, PhD · Kansas State University

  • Pratik Patel, MS, RD · Kansas State University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-02-29
Primary Completion
2012-05-31
Completion
2012-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02185872 on ClinicalTrials.gov